News | March 23, 2024
USFDA grants ODD to Cevidoplenib for immune thrombocytopenia
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Leading USA based genetic testing brand officially enters the Indian market
New facility is part of Aptar Pharma’s global expansion program
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Sets price band at ?695 to ?735 per Equity Share
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
